Abstract
Migraine headaches are common in children. Early diagnosis and appropriate interventions are mandatory to prevent decades of suffering and diminished quality of life. There is need for data regarding the efficacy and safety of prophylactic agents in children with migraine; therefore, we designed a randomized clinical trial to compare the efficacy and safety of cinnarizine with that of a well-known prophylactic agent (propranolol) in the prophylaxis of pediatric migraine headache. A total of 120 patients aged between 6 and 17 years were recruited and 113 patients succeeded in completing all phases of the trial. Of them, 57 patients were given cinnarizine, and propranolol was administered in 56 patients. Reduction in headache frequency was the main response to treatment. Cinnarizine reduced the baseline headache frequency by more than 50% in 74.6% of patients and the mean headache frequency per month was reduced from 11.851 ± 0.739 (mean ± SEM) to 3.358 ± 0.739 (mean ± SEM) attacks per month (P < 0.001). In the propranolol group, more than 50% reduction of the baseline headache frequency was seen in 72.5% of patients and the mean headache frequency per month was reduced from 10.264 ± 0.830 (mean ± SEM) to 2.774 ± 0.830 (mean ± SEM) attacks per month (P < 0.001). No significant difference was seen in 50% reduction of the baseline headache frequency between treatment groups (P = 0.358). No significant adverse effects were reported. In this open study, cinnarizine appeared thus as effective as propranolol and safe for the prophylaxis of migraine in children, but this remains to be confirmed in a double-blind placebo-controlled trial.
Similar content being viewed by others
References
Lewis D, Winner P, Saper J, Ness S, Polverejan E et al (2009) Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 123:924–934
Lewis DW (2009) Pediatric migraine. Neurol Clin 27:481–501
Pakalnis A (2006) Pediatric migraine: new diagnostic strategies and treatment options. Expert Rev Neurother 6:291–296
Pakalnis A (2002) Current therapies for prophylaxis of pediatric migraine. Expert Rev Neurother 2:555–559
Damen L, Bruijn J, Verhagen AP, Berger MY, Passchier J et al (2006) Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials. Cephalalgia 26:497–505
Caruso JM, Brown WD, Exil G, Gascon GG (2000) The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 40:672–676
Pakalnis A, Greenberg G, Drake ME Jr, Paolichi J (2001) Pediatric migraine prophylaxis with divalproex. J Child Neurol 16:731–734
Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC et al (2005) Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 45:1304–1312
Lakshmi CV, Singhi P, Malhi P, Ray M (2007) Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol 22:829–835
Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F (2005) Sodium valproate versus propranolol in paediatric migraine prophylaxis. Eur J Paediatr Neurol 9:333–338
Rao BS, Das DG, Taraknath VR, Sarma Y (2000) A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurol India 48:223–226
Cruz MJ, Valencia I, Legido A, Kothare SV, Khurana DS et al (2009) Efficacy and tolerability of topiramate in pediatric migraine. Pediatr Neurol 41:167–170
Sorge F, De Simone R, Marano E, Nolano M, Orefice G et al (1988) Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 8:1–6
Sorge F, Marano E (1985) Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia 5(Suppl 2):145–148
Battistella PA, Ruffilli R, Moro R, Fabiani M, Bertoli S et al (1990) A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 30:264–268
Rossi P, Fiermonte G, Pierelli F (2003) Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial. Funct Neurol 18:155–159
Togha M, Ashrafian H, Tajik P (2006) Open-label trial of cinnarizine in migraine prophylaxis. Headache 46:498–502
Petkov GV, Fusi F, Saponara S, Gagov HS, Sgaragli GP et al (2001) Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery. Acta Physiol Scand 173:257–265
Miller GS (2004) Efficacy and safety of levetiracetam in pediatric migraine. Headache 44:238–243
Dooley JM, Gordon KE (2006) The role of pharmacotherapy in pediatric migraine. Headache 46:195–196
Olesen J (2004) Headache Classification Sub-Committee of the International Headache Society. The International Classification of Headache Disorder, 2nd edn. Cephalagia 24(1):1–160
Turner D, Lurie Y, Finkelstein Y, Schmid T, Gopher A et al (2006) Pediatric cinnarizine overdose and toxicokinetics. Pediatrics 117:e1067–e1069
Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M et al (2004) Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63:2215–2224
Togha M, Rahmat Jirde M, Nilavari K, Ashrafian H, Razeghi S et al (2008) Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. J Headache Pain 9:77–82
Arab SF, Duwel P, Jungling E, Westhofen M, Luckhoff A (2004) Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn Schmiedebergs Arch Pharmacol 369:570–575
Pianese CP, Hidalgo LO, Gonzalez RH, Madrid CE, Ponce JE et al (2002) New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12 week, multinational, double-blind study. Otol Neurotol 23:357–363
Acknowledgments
We are extremely indebted to the authorities of the Research Deputy of Tehran University of Medical Sciences for their financial and logistic support. We offer our special thanks to patients and their parents for their cooperation.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Togha, M., Malamiri, R.A., Rashidi-Ranjbar, N. et al. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol. Acta Neurol Belg 112, 51–55 (2012). https://doi.org/10.1007/s13760-012-0011-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-012-0011-7